Mealey's ( June 21, 2017, 9:52 AM EDT) -- NEW ORLEANS — The plaintiff who lost the first Xarelto bellwether trial on June 12 filed a motion for a new trial in Louisiana federal court, arguing that the judge erred by excluding crucial evidence regarding information in the drug’s label in other countries and evidence from global medical associations (In re: Xarelto [Rivaroxaban] Products Liability Litigation, MDL 2592, Joseph Boudreaux Jr. v. Bayer Corp., et al., No. 14-cv-02720, E.D. La.)....